Gene therapy for hypertension: The preclinical data

Methods in Enzymology

Volumn 346, Issue , 2002, Pages 3-13

  Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ANTISENSE OLIGONUCLEOTIDE; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COMPLEMENTARY DNA; COMPLEMENTARY RNA; LENTIVIRUS VECTOR; LIPOSOME; PARVOVIRUS VECTOR; RECOMBINANT DNA; RETROVIRUS VECTOR; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VIRUS VECTOR;

ARTICLE; BRADYCARDIA; CENTRAL NERVOUS SYSTEM DISEASE; DNA SEQUENCE; GENE DELIVERY SYSTEM; GENE THERAPY; GENE TRANSFER; HERPES SIMPLEX VIRUS; HUMAN; HYPERTENSION; NONHUMAN; NUCLEIC ACID PROBE; PLASMID; PRIORITY JOURNAL; SIDE EFFECT; VASODILATATION; ADENO ASSOCIATED VIRUS; ANIMAL; GENE VECTOR; GENETICS; VASOCONSTRICTION;

ADENO-ASSOCIATED VIRUS; RODENTIA;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HYPERTENSION; OLIGONUCLEOTIDES, ANTISENSE; VASOCONSTRICTION; VASODILATION;

EID: 0036359785     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(02)46046-6     Document Type: Article

References (45)

1. N. M. Kaplan, "Clinical Hypertension." Williams and Wilkins, Baltimore, 1998.
2. R. P. Lifton, Science 272, 676 (1996).
3. R. Gyurko, D. Wielbo, and M. I. Phillips, Reg. Pept. 49, 167 (1993).
4. M. I. Phillips, D. Wielbo, and R. Gyurko, Kidney Intl. 46, 1554 (1994).
5. J. Chao and L. Chao, Immunopharmacology 36, 229 (1997).
6. K. F. Lin, J. Chao, and L. Chao, Hum. Gene Ther. 9, 1429 (1998).
7. J. Chao, L. Jim, K. F. Lin, and L. Chao, Hypertens. Res. 20, 2692 (1997).
8. K. F. Lin, L. Chao, and J. Chao, Hypertension 30, 307 (1997).
9. E. Dobrzynski, H. Yoshida, J. Chao, and L. Chao, Immunopharmacology 44, 57 (1999).
10. Y. C. Zhang, J. D. Bui, L. P. Shen, and M. I. Phillips, Circulation 101, 682 (2000).
11. Y. C. Zhang, B. Kimura, L. Shen, and M. I. Phillips, Hypertension 35, 219 (2000).
12. X. Jeunemaitre, F. Soubrier, Y. V. Kotelevetsev, R. P. Lifton, C. S. Williams, A. Charru, S. C. Hunt, P. N. Hopkins, R. R. Williams, and J. M. Lalouel, Cell 71, 169 (1992).
13. D. Wielbo, A. Simon, M. I. Phillips, and S. Toffolo, Hypertension 28, 147.
14. K. Makino, M. Sugano, S. Ohtsuka, and S. Sawada, Hypertension 31, 1166 (1998).
15. R. Gyurko, D. Tran, and M. I. Phillips, Am. J. Hypertension 10, 56S (1997).
16. S. Kaguyama, A. Varela, M. I. Phillips, and S. M. Galli, Hypertension (2001), in press.
17. J.-F Peng, B. Kimura, M. J. Fregly, and M. I. Phillips, Hypertension 31, 1317 (1998).
18. B. Li, J. A. Hughes, and M. I. Phillips, Neurochem. Intl. 31, 393 (1996).
19. S. T. Crooke, Methods Enzymol. 313, 3 (2000).
20. M. I. Phillips, Hypertension 29, 177 (1997).
21. P. Wu, M. I. Phillips, J. Bui, and E. F. Terwillinger, J. Virol. 72, 5919 (1998).
22. X. Tang, D. Mohuczy, C. Y. Zhang, B. Kimura, S. M. Galli, and M. I. Phillips, Am. J. Physiol. 277, H2392 (1999).
23. K. R. Lynch, V. I. Simnad, E. T. Ben Ari, and J. C. Garrison, Hypertension 8, 540 (1986).
24. S. Zolotukhin, M. Potter, W. W. Hauswirth, J. Guy, and N. A. Muzyczka, J. Virol. 70, 4646 (1996).
25. M. I. Phillips, D. Mohuczy-Dominiak, M. Coffey, S. M. Galli, W. Ping, and T. Zelles, Hypertension 29, 374 (1997).
26. B. Kimura, D. Mohuczy, X. Tang, and M. I. Phillips, Hypertension 37, 376 (2001).
27. S. N. Iyer, D. Lu, M. Katovich, and M. K. Raizada, Proc. Natl. Acad. Sci. U.S.A. 93, 9960 (1996).
28. M. I. Phillips, B. Kimura, Y.-C. Zhang, and C. H. Gelband, Hypertension 36, P204 (2000).
29. H. C. Champion, T. J. Bivalacqua, K. Toyoda, D. D. Hystad, A. L. Hyman, and P. J. Kadowitz, Circulation 101, 923 (2000).
30. M. I. Phillips, Hypertension 33, 8 (1999).
31. P. Y. Reaves, C. H. Gelband, H. Wang, H. Yang, D. Lu, K. H. Berecek, M. J. Katovich, and M. K. Raizada, Circ. Res. 86, E44 (1999).
32. P. Li, M. Morris, D. I. Diz, C. M. Ferrario, D. Ganten, and M. F. Callahan, Am. J. Physiol. 270, R1178 (1996).
33. S. Suzuki, P. Pilowsky, J. Minso, L. Arnolda, I. Llewellyn-Smith, and J. Chalmers, Circ. Res. 77, 679 (1995).
34. R. Morishita, J. Higaki, N. Tomita, M. Aoki, A. Moriguichi, K. Tamura, K. Murakami, Y. Kaneda, and T. Ogihara, Hypertension 27, 502 (1996).
35. T. Nishii, A. Moriguchi, R. Morishita, K. Yamada, S. Nakamura, N. Tomita, Y. Kaneda, A. Fukamizu, H. Mikami, J. Higaki, and T. Ogihara, Circ. Res. 85, 257 (1999).
36. I. Hayashi, M. Majima, T. Fujita, T. Okumura, Y. Kumagai, N. Tomita, R. Morishita, J. Higaki, and T. Ogiwara, Br. J. Pharmacol. 131, 820 (2000).
37. S. Suzuki, P. Pilowsky, J. Minson, L. Arnolda, I. J. Llewellyn-Smith, and J. Chalmers, Am. J. Physiol. 266, R1418 (1994).
38. M. J. Katovich, C. H. Gelband, P. Reaves, H. W. Wang, and M. K. Raizada, Am. J. Physiol. 277, H1260 (1999).
39. M. H. Wang, F. Zhang, J. Marji, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman, Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R255 (2001).
40. Y. Kaneda and T. Ogihara, Hypertension 26, 131 (1995).
41. S. M. Galli and M. I. Phillips, Hypertension 38, 543 (2001).
42. W. C. Wolf, H. Yoshida, J. Agata, L. Chao, and J. Chao, Kidney Int. 58, 7130 (2000).
43. J. J. Zhang, C. Wang, K. F. Lin, L. Chao, and J. Chao, Clin. Exp. Hypertens. 21, 1145 (1999).
44. E. Dobrzynski, C. Wang, J. Chao, and L. Chao, Hypertension 36, 995 (2000).
45. J. J. Zhang, H. Yoshida, L. Chao, and J. Chao, Hum. Gene Ther. 11, 1817 (2000).